pentobarbital will decrease the extent or effect of bedaquiline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Stay away from coadministration of bedaquiline with strong CYP3A4 inducers as a consequence of potential for reduced therapeutic impactpentobarbital will reduce the level or effect of bupren